Signostics is pioneering smart ultrasound devices to enhance imaging and clinical decision making in urologic care as the global leader of ultrasound innovation.
Clinicians had long been accustomed to using conventional handheld scanners to measure bladder volume. From their home base in Adelaide, Australia, the technologists at Signostics recognized how much more could be achieved through adoption of advances in microprocessing and software.
After the global commercialization of its first device in 2009, Signostics developed the SignosRT handheld ultrasound in 2013 and the SignosRT Bladder Scanner in 2014 – both offering groundbreaking accuracy, ease of use, and affordability.
Now, leveraging science from current day computer vision algorithms, Signostics technology has made a revolutionary advance with the introduction of Uscan – the world’s first smart mobile-connected ultrasound device targeted at urologic care.
Now under the leadership of CEO and industry pioneer Kevin Goodwin, Signostics has gained recognition and $35 million in funding though a capital commitment from the global investment firm KKR.
KKR’s investment is enabling Signostics to assemble the talent and infrastructure for the next wave of intelligent point-of-care ultrasound diagnostics, with enhanced feature recognition and analysis,
Signostics seeks to place the power of smart ultrasound diagnostics in the hands of more practitioners and facilities everywhere, to benefit an ever widening range of patients.

Company Growth (employees)
Bothell, US
Size (employees)
55 (est)+4%
Signostics was founded in 2005 and is headquartered in Bothell, US

Signostics Office Locations

Signostics has offices in Bothell, Clovelly Park, London and Suginami-ku
Bothell, US (HQ)
103 19125 North Creek Pkwy
London, GB
10 John St
Clovelly Park, AU
1284 South Rd

Signostics Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$44 m

Latest funding size

$35 m

Time since last funding

about 2 years


Signostics's latest funding round in November 2015 was reported to be $35 m. In total, Signostics has raised $44 m

Signostics's Web-traffic and Trends

Signostics Online and Social Media Presence

Signostics News and Updates

KKR invests $35 mln in EchoNous

Seattle-based EchoNous, the parent company of Signostics, an ultrasound tool for bladder and kidney care, has raised $35 million in funding. The investor was KKR.

Signostics Company Life and Culture

You may also be interested in